VERV
Verve Therapeutics
VERV
VERV
Delisted
VERV was delisted on the 24th of July, 2025.
95 hedge funds and large institutions have $1.66B invested in Verve Therapeutics in 2021 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 32 increasing their positions, 18 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
8% less capital invested
Capital invested by funds: $1.81B → $1.66B (-$151M)
33% less call options, than puts
Call options by funds: $501K | Put options by funds: $745K
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
95
Holding in Top 10
2
Calls
$501K
Puts
$745K
Top Buyers
| 1 | +$56.2M | |
| 2 | +$56M | |
| 3 | +$14.7M | |
| 4 |
BlackRock
New York
|
+$11M |
| 5 |
Rafferty Asset Management
New York
|
+$5.29M |
Top Sellers
| 1 | -$24.1M | |
| 2 | -$21M | |
| 3 | -$5.92M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.39M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.79M |